Visalli M - Search Results

1

Epidrugs in the Immunotherapy of Cutaneous and Uveal Melanoma.

Venza M, Visalli M, Catalano T, Beninati C, Teti D, Venza I. Venza M, et al. Among authors: visalli m. Anticancer Agents Med Chem. 2017;17(2):190-205. doi: 10.2174/1871520616666160425110401. Anticancer Agents Med Chem. 2017. PMID: 27109020 Review.

2

Impact of DNA methyltransferases on the epigenetic regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor expression in malignant melanoma.

Venza M, Visalli M, Catalano T, Fortunato C, Oteri R, Teti D, Venza I. Venza M, et al. Among authors: visalli m. Biochem Biophys Res Commun. 2013 Nov 29;441(4):743-50. doi: 10.1016/j.bbrc.2013.10.114. Epub 2013 Nov 5. Biochem Biophys Res Commun. 2013. PMID: 24211571

3

Epigenetic regulation of p14ARF and p16INK4A expression in cutaneous and uveal melanoma.

Venza M, Visalli M, Biondo C, Lentini M, Catalano T, Teti D, Venza I. Venza M, et al. Among authors: visalli m. Biochim Biophys Acta. 2015 Mar;1849(3):247-56. doi: 10.1016/j.bbagrm.2014.12.004. Epub 2014 Dec 11. Biochim Biophys Acta. 2015. PMID: 25497382

4

Involvement of epimutations in meningioma.

Venza M, Visalli M, Beninati C, Catalano T, Biondo C, Teti D, Venza I. Venza M, et al. Among authors: visalli m. Brain Tumor Pathol. 2015 Jul;32(3):163-8. doi: 10.1007/s10014-015-0221-9. Epub 2015 May 1. Brain Tumor Pathol. 2015. PMID: 25930103 Review.

5

The overriding of TRAIL resistance by the histone deacetylase inhibitor MS-275 involves c-myc up-regulation in cutaneous, uveal, and mucosal melanoma.

Venza M, Visalli M, Oteri R, Agliano F, Morabito S, Teti D, Venza I. Venza M, et al. Among authors: visalli m. Int Immunopharmacol. 2015 Sep;28(1):313-21. doi: 10.1016/j.intimp.2015.06.024. Epub 2015 Jun 27. Int Immunopharmacol. 2015. PMID: 26122536

6

Role of Genetics and Epigenetics in Mucosal, Uveal, and Cutaneous Melanomagenesis.

Venza M, Visalli M, Beninati C, Biondo C, Teti D, Venza I. Venza M, et al. Among authors: visalli m. Anticancer Agents Med Chem. 2016;16(5):528-38. doi: 10.2174/1871520615666150803124139. Anticancer Agents Med Chem. 2016. PMID: 26234362 Review.

7

IL-10Rα expression is post-transcriptionally regulated by miR-15a, miR-185, and miR-211 in melanoma.

Venza I, Visalli M, Beninati C, Benfatto S, Teti D, Venza M. Venza I, et al. Among authors: visalli m. BMC Med Genomics. 2015 Dec 3;8:81. doi: 10.1186/s12920-015-0156-3. BMC Med Genomics. 2015. PMID: 26631117 Free PMC article.

8

DNA methylation-induced E-cadherin silencing is correlated with the clinicopathological features of melanoma.

Venza M, Visalli M, Catalano T, Biondo C, Beninati C, Teti D, Venza I. Venza M, et al. Among authors: visalli m. Oncol Rep. 2016 Apr;35(4):2451-60. doi: 10.3892/or.2016.4618. Epub 2016 Feb 11. Oncol Rep. 2016. PMID: 26883095

9

DSS1 promoter hypomethylation and overexpression predict poor prognosis in melanoma and squamous cell carcinoma patients.

Venza M, Visalli M, Catalano T, Beninati C, Teti D, Venza I. Venza M, et al. Among authors: visalli m. Hum Pathol. 2017 Feb;60:137-146. doi: 10.1016/j.humpath.2016.10.018. Epub 2016 Nov 4. Hum Pathol. 2017. PMID: 27825810

10

Pseudomonas aeruginosa induces interleukin-8 (IL-8) gene expression in human conjunctiva through the recruitment of both RelA and CCAAT/enhancer-binding protein beta to the IL-8 promoter.

Venza I, Cucinotta M, Visalli M, De Grazia G, Oliva S, Teti D. Venza I, et al. Among authors: visalli m. J Biol Chem. 2009 Feb 13;284(7):4191-9. doi: 10.1074/jbc.M805429200. Epub 2008 Dec 8. J Biol Chem. 2009. PMID: 19064995 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

114 results

Search Page